[1]
N. T. T. Ha, D. H. Kien, and N. T. B. Phuong, “The safety of Pembrolizumab in advanced-stage non-small cell lung cancer patients”,
JCMHCH
, vol. 13, no. 67, pp. 77–82, Jan. 2025.